Jeff Eiseman
Long only, deep value, special situations

The Third Time's A Charm: How Tonix's Success With Its PTSD Trial Relates To Its Fibromyalgia Trial

(Editorial Note: With the exception of this note, the article's subtitle, and the concluding section, the article was submitted to Seeking Alpha at 2 AM on May 18. Its previous subtitle was: "Despite Its 49% Jump in 8 Trading Days, Tonix is Still 2016's Extraordinary Bargain." Even though the material between this note and the final new closing section without knowing that the PTSD trial had turned out successfully for Tonix (NASDAQ:TNXP), current and potential investors will find it useful to reflect upon the original article's basic messages about (1) the similarities between PTSD and fibromyalgia (NYSEARCA:FM), (2) why if it works in one it should work in the other, (3) why crushed oral CBP

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details